- tags:myopia
Pipeline
Eyenovia's phase 3 pediatric myopia trial fails primary goal
Company reports insignificant findings on drug-device combo of low-dose atropine and its Optejet system; announces next steps.
Research
Omnibus model identifies framework for effective myopia management
New research out of the 2024 AAOpt meeting investigates two key—but broad—areas of disease progression among pediatric patients.
Research
Outdoor exposure leads to less myopic shift among children
Researchers recommend at least 15 minutes of outdoor time with no less than 2,000 lux sunlight intensity.
Research
How does peripheral defocus impact pediatric myopia development?
Researchers explore whether peripheral defocus of the horizontal direction increases the risk of myopia development in children.
Research
Is weekly or daily atropine more effective for pediatric myopia management?
Weekly 1% atropine drops may be a potentially effective treatment in younger and mildly myopic patients.
Research
HOYA reports 8-year data on DIMS spectacle lenses for pediatric myopia
Long-term study evaluated myopia control effect and user experience of patients wearing HOYA’s MiYOSMART spectacle lenses.
Business
Global Myopia Awareness Coalition adds international members
The Singapore Optometric Association and Optometry Australia have joined the industry coalition’s fight against myopia.
Research
Short-term sunlight exposure impacts pediatric myopia development
New study investigates how sun exposure may impact fundus blood flow perfusion.
Research
How effective is ortho-k in slowing AL growth for pediatric myopia?
Ortho-k for myopia control was very effective and not effective in 40% and 25% of study participants respectively.
Research
Pivotal study supports B+L's TENEO laser for myopic LASIK surgery
Pivotal 9-month study on the FDA-approved excimer laser platform reports 97.8% and 100% of eyes achieving UCDVA and CDVA of 20/25 or better.
Research
AI and smartphone imaging may detect pediatric eye diseases
Predictive models demonstrate varying levels of accuracy and sensitivity in identifying myopia, strabismus, and ptosis.
Research
Physically active kids less likely to develop myopia
Cross-sectional study investigates physical activity’s effect on childhood myopia prevalence
Business
Sydnexis names long-time industry executive as new leader
Effective Aug. 5, Perry J. Sternberg will take over as CEO of the pediatric myopia-focused pharmaceutical company.
Research
Could computer-aided orthokeratology fittings surpass standard methods?
Recent study investigates the benefits of two new tech-based fitting methods for ortho-k.
Research
Data supports prior findings on red light therapy for pediatric myopia management
New research assesses the efficacy and safety of 650 nm LLRL for myopia treatment in children.
Events
JJV showcases Vision Made Possible, other key initiatives at Optometry's Meeting 2024
Johnson & Johnson Vision’s President of Americas discusses contact lens technologies, doctor-patient relationships, DEI initiatives, and advocacy efforts.
Events
The Myopia Collective selects over 60 ODs to lead US myopia control efforts
Inaugural cohort of Change Agents from across the country will lead the charge to disrupt the current standard of pediatric myopia care.
Research
Myopia Management Navigator targets global advancements in care
Myopia expert shares clinical input on this user-friendly digital platform designed for ECPs and patients.
Research
Atropine 0.05% for myopia shows promise in 5-year LAMP study
Extended data builds on prior 1-year and 3-year findings regarding atropine effectiveness for childhood myopia.
Pipeline